Shukra Pharmaceuticals Limited share price
NSE: SHUKRAPHAR · ISIN INE551C01044
Key numbers
- Market cap
- ₹ 2,465 Cr
- Current price
- ₹ 55.93
- 52-week high / low
- ₹ 60 / 40
- Stock P/E
- 71.7
- Book value
- ₹ 2.1
- Dividend yield
- 0.02%
- ROCE
- 36.9%
- ROE
- 28.9%
- Debt to equity
- 0.06
- Sales growth (3 yrs)
- -1.2%
- Profit growth (3 yrs)
- 71.0%
- 1-year return
- -
About Shukra Pharmaceuticals Limited
Shukra Pharmaceuticals Limited engages in the manufacturing, marketing, and export of pharmaceutical formulations in India and internationally. The company offers various products, such as antibiotics, anti biotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products. It provides its products in ampoules, capsules, vials, and tablet forms. In addition, the company provides laboratory services; and surgical robots, diabetes technologies, cardiac sciences, advanced surgical and diagnostic solutions, imaging and critical care, medical simulations, wound care, boron neutron capture therapy, and virtual autopsy and forensic sciences. Further, it is involved in the supplying, selling, and distributing medical consumables; offers wound care products, medical, surgical, healthcare devices, materials, consumables, and allied solutions, as well as diabetes-related medical…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 5 | 6 | 39 | 6 | 24 |
| Operating profit | 1 | -0 | 27 | 1 | 19 |
| Net profit | 1 | 2 | 20 | -2 | 13 |
| EPS (₹) | 0.02 | 0.05 | 0.47 | -0.04 | 0.30 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.